Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 8—August 2018
CME ACTIVITY - Synopsis

Unilateral Phrenic Nerve Palsy in Infants with Congenital Zika Syndrome

Nipunie S. RajapakseComments to Author , Kevin Ellsworth, Rachael M. Liesman, Mai Lan Ho, Nancy Henry, Elitza S. Theel, Adam Wallace, Ana Catarina Ishigami Alvino, Luisa Medeiros de Mello, and Jucille Meneses
Author affiliations: Author affiliations: Mayo Clinic, Rochester, Minnesota, USA (N.S. Rajapakse, K. Ellsworth, R.M. Liesman, M.L. Ho, N. Henry, E.S. Theel, A. Wallace); Professor Fernando Figueira Integral Medicine Institute, Recife, Brazil (A.C. Ishigami Alvino, L.M. de Mello, J. Meneses)

Main Article

Table

Summary of maternal and infant characteristics in 4 cases of congenital Zika syndrome in infants who had unilateral elevation of the diaphragm*

Characteristics Patient 1 Patient 2 Patient 3 Patient 4
Maternal characteristics
Maternal age, y 27 21 17 21
Prenatal care Yes Yes Yes Yes
Zika virus symptoms, trimester 1st 1st 1st 1st
Fever + +
Rash + + +
Arthralgia +
Abnormal fetal ultrasound, trimester
3rd
3rd
2nd
3rd
Infant characteristics
Delivery type Cesarean Cesarean Vaginal Cesarean
Sex F F F F
Gestational age, wk 38 40 39 41
Birthweight, g 2,020 2,025 2,565 2,075
Length, cm 40 42 46 41
HC at birth, cm 27.5 28.5 28 28
z-score −4.3 −4.3 −4.2 −4.9
Arthrogryposis Hips, knees, ankles, elbows Hips, ankles, wrists Hips, ankles, wrists Hips, ankles, wrists
Talipes equinovarus + + + +
Head imaging findings V, C, H V V, C, H V, C
Elevated right hemidiaphragm + + + +
Cause of death Respiratory failure Respiratory failure Respiratory failure Respiratory failure
Day of life
13
10
86
4
Maternal testing for Zika virus
RT-PCR
Amniotic fluid NA NA + NA
Serum NA NA
IgM, serum

NA


Infant testing
RT-PCR for Zika virus
Serum
CSF NA +
Urine NA NA NA
Placenta NA NA NA
Zika virus IgM
Serum + + + +
CSF
NA
+
+
+
PRNT titer
Zika virus >1:1,280 180† 897† 270†
DENV-1 1:10 <20 <20 <20
DENV-2 <1:10 <20 <20 <20

*C, calcifications; CSF, cerebrospinal fluid; DENV, dengue virus; H, cerebral hypoplasia; HC, head circumference; NA, not available; PRNT, plaque reduction neutralization test; RT-PCR, reverse transcription PCR; V, ventriculomegaly; +, positive finding/test result; –, negative finding/test result.
†Indicates 50% plaque reduction neutralization test titer.

Main Article

Page created: July 11, 2018
Page updated: July 11, 2018
Page reviewed: July 11, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external